Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis

Journal of Clinical Microbiology

Volumn 44, Issue 3, 2006, Pages 1098-1100

  Qi, Chao ^a,b   Zheng, Xiaotian ^a,c   Obias, Arlene ^b   Scheetz, Marc H ^b   Malczynski, Michael ^b   Warren, John R ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RNA 23S;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CONTROLLED STUDY; DILUTION; DISK DIFFUSION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE MUTATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BASE SEQUENCE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 33644898879     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.3.1098-1100.2006     Document Type: Article

References (16)

1. Auckland, C., L. Teare, F. Cooke, M. E. Kaufman, M. Warner, G. Jones, K. Bamford, H. Ayles, and A. P. Johnson. 2002. Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J. Antimicrob. Chem. 50:743-746.
2. Bersos, Z., M. Maniati, F. Kontos, E. Petinaki, and A. N. Maniatis. 2004. First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece. J. Antimicrob. Chem. 53:685-686.
3. Birmingham, M. C., C. R. Rayner, A. K. Meagher, S. M. Flavin, D. H. Batts, and J. J. Schentag. 2003. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin. Infect. Dis. 36:159-168.
4. Clinical and Laboratory Standards Institute, 2003. Performance standards for antimicrobial disk susceptibility tests, 8th ed. Approved standard M2-A8. Clinical and Laboratory Standards Institute, Wayne, Pa.
5. Clinical and Laboratory Standards Institute. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. Clinical and Laboratory Standards Institute, Wayne, Pa.
6. Clinical and Laboratory Standards Institute. 2005. Performance standard for antimicrobial susceptibility testing; fifteenth informational supplement Approved standard M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
7. Dibo, I., S. K. Pillai, H. S. Gold, M. R. Baer, M. Wetzler, J. L. Slack, P. A. Hazamy, D. Ball, C. B. Hsiao, P. L. McCarthy, Jr, and B. H. Segal. 2004. Linezolid-resistant Enterococcus faecalis isolated from a cord blood tram plant recipient. J. Clin. Microbiol. 42:1843-1845.
8. Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme J. Clin. Microbiol. 27:731-734.
9. Gonzales, R. D., P. C. Schreckenberger, M. B. Graham, S. Kelkar, K. DenBesten, and J. P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357:1179.
10. Lobritz, M., R. Hutton-Thomas, S. Marshall, and L. B. Rice. 2003. Recombination proficiency influences frequency and locus of mutational resistance to linezolid i Enterococcusfaecalis. Antimicrob. Agents Chemother. 47:3318-3320.
11. Marshall, S. H., C. J. Donskey, R. Hutton-Thomas, R. A. Salata, and L. B. Rice. 2002. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 46:3334-3336.
12. Pai, M. P., K. A. Rodvold, P. C. Schreckenberger, R. D. Gonzales, J. M. Petrolatti, and J. P. Quinn. 2002. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clin. Infect. Dis. 35:1269-1272.
13. Prystowsky, J., F. Siddiqui, J. Chosay, D. L. Shinabarger, J. Millichap, L. R. Peterson, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45:2154-2156.
14. Raad, I. I., H. A. Hanna, R. Y. Hachem, T. Dvorak, R. B. Arbuckle, G. Chaiban, and L. B. Rice. 2004. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob. Agents Chemother. 48:3583-3585.
15. Ruggero, K. A., L. K. Schroeder, P. C. Schreckenberger, A. S. Mankin, and J. P. Quinn. 2003. Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid: MICs. Diagn. Microbiol. Infect. Dis. 47:511-513.
16. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel eJectrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.